Forward Citations = 0

Loading Chart...

8 inventors (with patents filed for the assignee):

Li Huang Xing (4 out of 26 patents)

Xiang Y Yu (4 out of 35 patents)

Minghua Wang (4 out of 32 patents)

4. Michael Silverman (4 out of 7 patents)

5. Richard M Soll (4 out of 71 patents)

6. Casey Cameron McComas (3 out of 42 patents)

7. Casey McCOMAS (1 out of 1 patent)

8. Kevin Garey (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12534470 - DNA polymerase IIIC inhibitors and use thereof (2026-01-27),

2. 12036225 - Use of ibezapolstat to promote microbiome health (2024-07-16),

3. 11001592 - DNA polymerase IIIC inhibitors and use thereof (2021-05-11),

4. 10836772 - DNA polymerase IIIC inhibitors and use thereof (2020-11-17),

5. 10723741 - DNA polymerase IIIC inhibitors and use thereof (2020-07-28),

Company Overview

Acurx Pharmaceuticals, LLC is a biopharmaceutical company focused on developing novel antibiotics to combat serious and life-threatening infections. With a commitment to addressing the growing threat of antimicrobial resistance, Acurx is dedicated to advancing innovative solutions for infectious diseases. The company's pipeline includes promising candidates with the potential to offer new treatment options for patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#39 in White Plains, NY

#3,131 in New York

#51,620 in US

White Plains, NY, United States of America

Acurx Pharmaceuticals, LLC

Forward Citations = 0

8 inventors:

Li Huang Xing (4 out of 26 patents)

Xiang Y Yu (4 out of 35 patents)

Minghua Wang (4 out of 32 patents)

4. Michael Silverman (4 out of 7 patents)

5. Richard M Soll (4 out of 71 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Acurx Pharmaceuticals, LLC. Retrieved from https://idiyas.com/company/acurx-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]